Bioheart Inc (BHRT.PK)

BHRT.PK on OTC Markets Group

0.03USD
20 May 2013
Price Change (% chg)

$-0.00 (-11.67%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.03
Volume
373,888
Avg. Vol
1,299,247
52-wk High
$0.06
52-wk Low
$0.00

BHRT.PK

Chart for BHRT.PK

About

Bioheart, Inc. is a development-stage, biotechnology company. The Company focuses on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. MyoCell is a clinical muscle-derived cell therapy designed to populate regions of... (more)

Buy/Sell

No analyst recommendations are available for BHRT.PK.
» Analyst Consensus

Overall

Beta: 1.71
Market Cap (Mil.): $6.02
Shares Outstanding (Mil.): 200.62
Dividend: --
Yield (%): --

Financials

  BHRT.PK Industry Sector
P/E (TTM): -- 53.78 35.83
EPS (TTM): -0.03 -- --
ROI: -- 1.00 18.72
ROE: -- 2.10 19.54
Search Stocks

Competitors

  Price Change
Medtronic, Inc. (MDT.N) $49.89 +0.05
Baxter International Inc. (BAX.N) $72.94 0.00
St. Jude Medical, Inc. (STJ.N) $46.72 -0.28
WorldHeart Corporation (USA) (WHRT.OQ) -- --
Boston Scientific Corporation (BSX.N) $9.25 +0.15
Edwards Lifesciences Corp (EW.N) $66.37 -0.69
Pfizer Inc. (PFE.N) $28.70 -0.26
Sanofi SA (SASY.PA) €84.31 -0.19
Cytori Therapeutics Inc. (USA) (CYTX.OQ) $2.50 -0.13
Advanced Cell Technology, Inc. (ACTC.OB) $0.07 -0.00

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Bioheart, Inc. (BHRT) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Bioheart Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks